首页> 美国卫生研究院文献>Journal of the Royal Society Interface >A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants
【2h】

A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants

机译:原始抗原性罪过的简单机理解释及其佐剂的缓解

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A large number of published studies have shown that adaptive immunity to a particular antigen, including pathogen-derived, can be boosted by another, cross-reacting antigen while inducing suboptimal immunity to the latter. Although this phenomenon, called original antigenic sin (OAS), was first reported approximately 70 years ago (Francis et al. 1947 Am. J. Public Health 37, 1013–1016 ()), its underlying biological mechanisms are still inadequately understood (Kim et al. Proc. Natl Acad. Sci. USA 109, 13 751–13 756 ()). Here, focusing on the humoral aspects of adaptive immunity, I propose a simple and testable mechanism: that OAS occurs when T regulatory cells induced by the first antigen decrease the dose of the second antigen that is loaded by dendritic cells and available to activate naive lymphocytes. I use both a parsimonious mathematical model and experimental data to confirm the deductive validity of this proposal. This model also explains the puzzling experimental observation that administering certain dendritic cell-activating adjuvants during antigen exposure alleviates OAS. Specifically, the model predicts that such adjuvants will attenuate T regulatory suppression of naive lymphocyte activation. Together, these results suggest additional strategies for redeeming adaptive immunity from the destructive consequences of antigenic ‘sin’.
机译:大量已发表的研究表明,对另一种抗原(包括病原体衍生的抗原)的适应性免疫可以被另一种交叉反应的抗原增强,同时诱导对该抗原的次优免疫。尽管大约70年前首次报道了这种被称为原始抗原罪(OAS)的现象(Francis等,1947 Am。J. Public Health 37,1013–1016()),但其潜在的生物学机制仍未得到足够的了解(Kim et al.Proc.Natl Acad.Sci.USA 109,13 751–13 756())。在这里,我着眼于适应性免疫的体液方面,我提出了一个简单且可检验的机制:当由第一种抗原诱导的T调节细胞减少树突状细胞负载的可用于激活幼稚淋巴细胞的第二种抗原的剂量时,就会发生OAS 。我同时使用简化的数学模型和实验数据来证实该提议的推论有效性。该模型还解释了令人费解的实验观察,即在抗原暴露期间给予某些树突状细胞激活佐剂可缓解OAS。具体而言,该模型预测此类佐剂将减弱T细胞对幼稚淋巴细胞活化的调节性抑制。在一起,这些结果提出了从抗原性“罪恶”的破坏性后果中挽救适应性免疫力的其他策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号